Systematic prioritization of functional variants and effector genes underlying colorectal cancer risk

Genome-wide association studies of colorectal cancer (CRC) have identified 170 autosomal risk loci. However, for most of these, the functional variants and their target genes are unknown. Here, we perform statistical fine-mapping incorporating tissue-specific epigenetic annotations and massively parallel reporter assays to systematically prioritize functional variants for each CRC risk locus. We identify plausible causal variants for the 170 risk loci, with a single variant for 40. We link these variants to 208 target genes by analyzing colon-specific quantitative trait loci and implementing the activity-by-contact model, which integrates epigenomic features and Micro-C data, to predict enhancer-gene connections. By deciphering CRC risk loci, we identify direct links between risk variants and target genes, providing further insight into the molecular basis of CRC susceptibility and highlighting potential pharmaceutical targets for prevention and treatment.

Authors

Institutions

Publication Details

Journal
Nature Genetics
Published
2024-09-16
DOI
https://doi.org/10.1038/s41588-024-01900-w
Citations
6
Primary Topic
Genetic factors in colorectal cancer
Type
article
Field-Weighted Citation Impact
2.55

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Systematic prioritization of functional variants and effector genes underlying colorectal cancer risk

Malcolm G. Dunlop, Bradley T. Harris, Richard S. Houlston, Philip Law et al.
6 citations
Nature Genetics
Genetic factors in colorectal cancer
2.55
article

Systematic prioritization of functional variants and effector genes underlying colorectal cancer risk

Malcolm G. Dunlop, Bradley T. Harris, Richard S. Houlston, Philip Law, James S. Smith, James B. Studd, Jayaram Vijayakrishnan, Maria Mandelia, C. Mills
article en
6 citations

Abstract

Genome-wide association studies of colorectal cancer (CRC) have identified 170 autosomal risk loci. However, for most of these, the functional variants and their target genes are unknown. Here, we perform statistical fine-mapping incorporating tissue-specific epigenetic annotations and massively parallel reporter assays to systematically prioritize functional variants for each CRC risk locus. We identify plausible causal variants for the 170 risk loci, with a single variant for 40. We link these variants to 208 target genes by analyzing colon-specific quantitative trait loci and implementing the activity-by-contact model, which integrates epigenomic features and Micro-C data, to predict enhancer-gene connections. By deciphering CRC risk loci, we identify direct links between risk variants and target genes, providing further insight into the molecular basis of CRC susceptibility and highlighting potential pharmaceutical targets for prevention and treatment.

Nature GeneticsVol. 56(10)
Institute of Cancer Research (GB), Wellcome Sanger Institute (GB), Edinburgh Cancer Research (GB)
Wellcome, Wellcome Trust, Cancer Research UK, Medical Research Council
Good health and well-being
Openalex Percentile: Top 10%
Genetic factors in colorectal cancer
2.55
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.